Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a randomized phase III trial (ARTEG)

被引：0
|
作者：
Jinwen Shen
Xiu Zhu
Yian Du
Yuan Zhu
Pengfei Yu
Litao Yang
Zhiyuan Xu
Ling Huang
Yunli Zhang
Yanqiang Zhang
Luying Liu
Xiangdong Cheng
机构：
[1] Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital),Department of Abdominal Radiotherapy
[2] Zhejiang Provincial Research Center for Cancer of Upper Gastrointestinal Tract,Department of Pathology
[3] Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital),Department of Abdominal Surgery
[4] Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital),undefined
来源：
Trials | / 22卷
关键词：
Esophagogastric junction adenocarcinoma; D2 radical resection; Adjuvant chemoradiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study
    Lei Chen
    Chenghai Zhang
    Zhendan Yao
    Ming Cui
    Jiadi Xing
    Hong Yang
    Nan Zhang
    Maoxing Liu
    Kai Xu
    Fei Tan
    Yuzhe Li
    Beihai Jiang
    Xiangqian Su
    BMC Cancer, 21
  • [22] Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study
    Chen, Lei
    Zhang, Chenghai
    Yao, Zhendan
    Cui, Ming
    Xing, Jiadi
    Yang, Hong
    Zhang, Nan
    Liu, Maoxing
    Xu, Kai
    Tan, Fei
    Li, Yuzhe
    Jiang, Beihai
    Su, Xiangqian
    BMC CANCER, 2021, 21 (01)
  • [23] A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082)
    Furusawa, Akiko
    Takekuma, Munetaka
    Mori, Keita
    Usami, Tomoka
    Kondo, Eiji
    Nishio, Shin
    Nishino, Koji
    Miyamoto, Yuichiro
    Yoshimura, Ryoichi
    Watanabe, Miho
    Mikami, Mikio
    Enomoto, Takayuki
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (04) : 623 - 626
  • [24] Randomized phase III trial of adjuvant sequential chemotherapy plus radiotherapy versus adjuvant radiotherapy alone for locally advanced bladder cancer after radical cystectomy: Urothelial carcinoma subgroup analysis.
    Zaghloul, Mohamed S.
    Christodouleas, John Paul
    Hwang, Wei-Ting
    Smith, Andrew
    Abdalla, Ahmed
    William, Hany
    Baumann, Brian Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [25] Adjuvant oxaliplatin plus S-1 (SOX) with concurrent radiotherapy versus SOX alone for gastric cancer with D2 lymph node dissection and high risk factors: a randomized phase III trial
    Wang, X.
    Shen, Y.
    Li, Q.
    Qiu, M.
    Li, Z.
    Liu, J.
    Gou, H.
    Yang, Y.
    Cao, D.
    Yi, C.
    Luo, D.
    Zhu, H.
    Zhou, Z.
    Tan, S.
    Wang, W.
    Ye, X.
    Su, X.
    Xu, F.
    Bi, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [26] A randomized, multicenter, controlled study to compare perioperative chemotherapy of oxaliplatin combined with TS-1 (SOX) versus SOX or oxaliplatin with capecitabine (XELOX) as post-operative chemotherapy in locally advanced gastric adenocarcinoma with D2 dissection (RESOLVE Trial)
    Ji, Jiafu
    Shen, Lin
    Liang, Han
    Xue, Yingwei
    Zhang, Xiaotian
    Wang, Yanong
    Zhou, Zhiwei
    Du, Yian
    Xinbao, Wang
    Li, Guoli
    Yu, Jiren
    Wu, Dan
    Chen, Li
    Xiao, Gang
    He, Yulong
    Dang, Chengxue
    Zhang, Zhongtao
    Zhou, Yanbing
    Sun, Yihong
    Li, Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] Perioperative chemotherapy vs. adjuvant chemotherapy for potentially resectable gastric cancer: A randomized and multicenter phase III study in locally advanced gastric cancer with D2 dissection.
    Zhao, Qun
    Li, Yong
    Lian, Changhong
    Li, Baozhong
    Li, Wenxin
    Huo, Zhibin
    Wang, Zunyi
    Wang, Yimin
    Tian, Yuan
    Xie, Shuzhe
    Li, Shoumiao
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV
    Sylvie Lorenzen
    Alexander Biederstädt
    Ulrich Ronellenfitsch
    Christoph Reißfelder
    Stefan Mönig
    Frederik Wenz
    Claudia Pauligk
    Martin Walker
    Salah-Eddin Al-Batran
    Bernhard Haller
    Ralf-Dieter Hofheinz
    BMC Cancer, 20
  • [29] Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): Study protocol for a randomized controlled pilot trial
    Blank S.
    Knebel P.
    Haag G.-M.
    Bruckner T.
    Klaiber U.
    Burian M.
    Schaible A.
    Sisic L.
    Schmidt T.
    Diener M.K.
    Ott K.
    Pilot and Feasibility Studies, 2 (1)
  • [30] A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy (CCRT) for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082).
    Furusawa, Akiko
    Takekuma, Munetaka
    Usami, Tomoka
    Kondo, Eiji
    Nishio, Shin
    Nishino, Koji
    Miyamoto, Yuichiro
    Yoshimura, Ryoichi
    Watanabe, Miho
    Mikami, Mikio
    Enomoto, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345